HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.

AuthorsGil Yosipovitch, Peter A Lio, David Rosmarin, Esther Serra-Baldrich, Franz J Legat, Marta Casillas, Evangeline Pierce, Zhuqing Liu, Luna Sun, Hany Elmaraghy, Sonja Ständer
JournalThe British journal of dermatology (Br J Dermatol) (Nov 06 2023) ISSN: 1365-2133 [Electronic] England
PMID37939793 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: